MoonLake Immunotherapeutics
MLTX
#3631
Rank
S$3.95 B
Marketcap
$62.78
Share price
0.87%
Change (1 day)
-19.44%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2024 (TTM): -S$0.15 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$73.14 Million, an increase over its 2022 earnings that were of -S$87.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.15 Billion95.92%
2023 -S$73.14 Million-16.81%
2022 -S$87.92 Million